Procter & Gamble Pharmaceuticals

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Procter & Gamble Pharmaceuticals - overview

Established

1837

Location

Cincinnati, OH, US

Primary Industry

Pharmaceuticals

About

Procter & Gamble Pharmaceuticals is a global entity specializing in consumer goods and personal care products aimed at enhancing everyday living through effective solutions in hygiene and cleanliness. Founded in 1837 and headquartered in Cincinnati, US, Procter & Gamble Pharmaceuticals focuses on developing consumer goods across various sectors. The company has undergone strategic shifts over its long history, including a significant acquisition by Warner Chilcott in 2009 for approximately USD 3. 1 bn.


The firm has engaged in one known deal, emphasizing its established market presence. Procter & Gamble Pharmaceuticals offers a diverse array of consumer goods, including household cleaning agents, personal hygiene items, and beauty products. These offerings are engineered to address consumer needs around cleanliness and grooming, targeting families and professionals. The company maintains a strong distribution network, selling its products across North America, Europe, and parts of Asia.


The company's revenue for the most recent fiscal year, 2009, was USD 2. 30 bn. The revenue generation strategy is supported through a multi-channel distribution approach, combining partnerships with major retailers and direct-to-consumer sales, which facilitates access to a wide audience. Procter & Gamble Pharmaceuticals aims to launch new products designed with advanced efficacy in mind, though specific release dates have not been disclosed.


The firm plans to expand its market presence in emerging regions, targeting new geographic areas. The recent acquisition deal in 2009 will likely facilitate resource allocation toward these growth initiatives.


Current Investors

Warner Chilcott

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.us.pg.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Procter & Gamble Pharmaceuticals - financials

Fiscal Year EndedJan 01, 2009
Revenue (USD)-
% Revenue Growth (YoY)-
EBITDA (USD)-
Operating Income (USD)-
Operating Margin-
% EBITDA Margin-
NET Income (USD)-
% Net Margin-

Procter & Gamble Pharmaceuticals - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedZest Soap Brand-
Trade SaleCompletedMDVIP, LLC-
Add-onCompletedProcter & Gamble Pharmaceuticals-
Trade SaleCompletedFrederic Fekkai & Co.-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.